» Articles » PMID: 28131464

Need for Evidence and Consensus on Laser Treatment for Management of Select Primary Penile Tumors

Overview
Journal Eur Urol
Specialty Urology
Date 2017 Jan 30
PMID 28131464
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Laser ablation for low-risk primary penile tumors (Ta, Tis, and T1, preferably of low grade) offers satisfactory oncologic outcomes and excellent functional outcomes. Patients require long-term close surveillance given the substantial likelihood of local recurrence, and must adhere to strict follow-up protocols.

Citing Articles

Oncologic control and predictors of urologic reconstruction after Mohs micrographic surgery for low-risk penile malignancy.

Cortese B, Chelluri R, Skokan A, Xia L, Ostrowski D, Roberson D Int Urol Nephrol. 2024; 56(12):3727-3732.

PMID: 38922534 PMC: 11534996. DOI: 10.1007/s11255-024-04121-6.


Penile-sparing modalities in the management of low-stage penile cancer.

Babbar P, Yerram N, Crane A, Sun D, Ericson K, Sun A Urol Ann. 2018; 10(1):1-6.

PMID: 29416267 PMC: 5791443. DOI: 10.4103/UA.UA_93_17.